283 related articles for article (PubMed ID: 32696443)
1. The Role of Hyperbaric Oxygen Treatment for COVID-19: A Review.
Paganini M; Bosco G; Perozzo FAG; Kohlscheen E; Sonda R; Bassetto F; Garetto G; Camporesi EM; Thom SR
Adv Exp Med Biol; 2021; 1289():27-35. PubMed ID: 32696443
[TBL] [Abstract][Full Text] [Related]
2. The outcomes of COVID-19 measures in a hyperbaric oxygen therapy centre during the pandemic.
Ozgok-Kangal K; Zaman T; Koc B
Int Marit Health; 2021; 72(3):228-236. PubMed ID: 34604994
[TBL] [Abstract][Full Text] [Related]
3. Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a retrospective case series.
Thibodeaux K; Speyrer M; Raza A; Yaakov R; Serena TE
J Wound Care; 2020 May; 29(Sup5a):S4-S8. PubMed ID: 32412891
[TBL] [Abstract][Full Text] [Related]
4. Hyperbaric oxygen treatment for long coronavirus disease-19: a case report.
Bhaiyat AM; Sasson E; Wang Z; Khairy S; Ginzarly M; Qureshi U; Fikree M; Efrati S
J Med Case Rep; 2022 Feb; 16(1):80. PubMed ID: 35168680
[TBL] [Abstract][Full Text] [Related]
5. Hyperbaric oxygen therapy may be effective to improve hypoxemia in patients with severe COVID-2019 pneumonia: two case reports.
Guo D; Pan S; Wang M; Guo Y
Undersea Hyperb Med; 2020; 47(2):181-187. PubMed ID: 32574433
[TBL] [Abstract][Full Text] [Related]
6. The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review.
Oliaei S; SeyedAlinaghi S; Mehrtak M; Karimi A; Noori T; Mirzapour P; Shojaei A; MohsseniPour M; Mirghaderi SP; Alilou S; Shobeiri P; Azadi Cheshmekabodi H; Mehraeen E; Dadras O
Eur J Med Res; 2021 Aug; 26(1):96. PubMed ID: 34412709
[TBL] [Abstract][Full Text] [Related]
7. Hyperbaric oxygen therapy as a supportive therapy for COVID-19 patients: a narrative review.
Allam NM; Eladl HM; Eid MM
Eur Rev Med Pharmacol Sci; 2022 Aug; 26(15):5618-5623. PubMed ID: 35993661
[TBL] [Abstract][Full Text] [Related]
8. Physiologic and biochemical rationale for treating COVID-19 patients with hyperbaric oxygen.
Feldmeier JJ; Kirby JP; Buckey JC; Denham DW; Evangelista JS; Gelly HB; Harlan NP; Mirza ZK; Ray KL; Robins M; Savaser DJ; Wainwright S; Bird N; Huang ET; Moon RE; Thom SR; Weaver LK
Undersea Hyperb Med; 2021; 48(1):1-12. PubMed ID: 33648028
[TBL] [Abstract][Full Text] [Related]
9. Hyperbaric oxygen as a treatment for COVID-19 infection?
Moon RE; Weaver LK
Undersea Hyperb Med; 2020; 47(2):177-179. PubMed ID: 32574432
[TBL] [Abstract][Full Text] [Related]
10. Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.
Kjellberg A; Douglas J; Pawlik MT; Kraus M; Oscarsson N; Zheng X; Bergman P; Frånberg O; Kowalski JH; Nyren SP; Silvanius M; Skold M; Catrina SB; Rodriguez-Wallberg KA; Lindholm P
BMJ Open; 2021 Jul; 11(7):e046738. PubMed ID: 34226219
[TBL] [Abstract][Full Text] [Related]
11. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
12. UHMS Position Statement: Hyperbaric Oxygen (HBO2) for COVID-19 Patients.
Undersea Hyperb Med; 2020; 47(2):297-298. PubMed ID: 32574446
[TBL] [Abstract][Full Text] [Related]
13. Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls.
Gorenstein SA; Castellano ML; Slone ES; Gillette B; Liu H; Alsamarraie C; Jacobson AM; Wall SP; Adhikari S; Swartz JL; McMullen JJS; Osorio M; Koziatek CA; Lee DC
Undersea Hyperb Med; 2020; 47(3):405-413. PubMed ID: 32931666
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
15. Proactive COVID-19 Infection Prevention Measures in a Hyperbaric Oxygen Therapy Center.
Lo JJ; Wang SC; Lee HY; Lee SS; Lee HC; Hung CT; Huang SH
Medicina (Kaunas); 2020 May; 56(6):. PubMed ID: 32471203
[TBL] [Abstract][Full Text] [Related]
16. Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality.
Geier MR; Geier DA
Med Hypotheses; 2020 Jul; 140():109760. PubMed ID: 32344310
[TBL] [Abstract][Full Text] [Related]
17. Hyperbaric oxygen therapy for paediatric patients: an unintended consequence of the COVID-19 pandemic.
El Hawa AAA; Bekeny JC; Phillips NW; Johnson-Arbor K
J Wound Care; 2021 Sep; 30(Sup9):S24-S28. PubMed ID: 34554855
[TBL] [Abstract][Full Text] [Related]
18. Hyperbaric oxygen therapy for the treatment of long COVID.
Wilmshurst P; Bewley S; Murray P
Clin Med (Lond); 2023 Jan; 23(1):99-100. PubMed ID: 36697009
[No Abstract] [Full Text] [Related]
19. Hyperbaric oxygen therapy in long-COVID-19 disease.
García Estévez DA; López Pérez Á; Gómez Márquez H
Med Clin (Barc); 2023 Dec; 161(11):498-499. PubMed ID: 37775412
[No Abstract] [Full Text] [Related]
20. SARS-CoV-2 lung disease in a patient with pulmonary sarcoidosis - case report.
Opoka LM; Wyrostkiewicz D; Winek J; Błasińska K; Miłkowska-Dymanowska J; Szturmowicz M
Adv Respir Med; 2020; 88(6):620-625. PubMed ID: 33393657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
